Joyce O'Shaughnessy

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Commitee
Sarah Cannon Research Institute
Dallas, Texas

Explore Activities by Joyce O'Shaughnessy

Title
Format
Credit Type
Credits
CCO Independent Conference Highlights of the 2024 San Antonio Breast Cancer Symposium

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.50
An Expert’s Guide to SABCS 2024: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Conversaciones sobre el cáncer de mama RH positivo/HER2 negativo en el panorama terapéutico en expansión de los inhibidores de CDK4/6

Content Format:

PDF

Credit Type:

--

Credits:

--
Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo

Content Format:

PDF

Credit Type:

--

Credits:

--
Des experts répondent à vos questions concernant les inhibiteurs de CDK4/6 dans le cancer du sein HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
Conversations autour du cancer portant sur l'élargissement du paysage thérapeutique des inhibiteurs de CDK4/6 dans le traitement du cancer du sein HR+/HER2-

Content Format:

PDF

Credit Type:

--

Credits:

--
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Experts Answer Your Questions on CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Content Format:

Clinical Thought

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Cancer Conversations on the Expanding Therapeutic Landscape for CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Highlights From the 2023 San Antonio Breast Cancer Symposium

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.25
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Breast, Lung, Gastrointestinal, Genitourinary, and Skin Cancers: CCO Independent Conference Highlights of the 2023 ESMO Congress

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.50
HR-Positive/HER2-Negative Breast Cancer: Patient–Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Educational Opportunities to Improve Community Healthcare Professionals’ Management of High-Risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to SABCS 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
An Expert’s Guide to ESMO 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Applying the Latest Developments in Metastatic Breast Cancer Through Education of Healthcare Professionals, Patients, and Caregivers

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting AKT in Breast Cancer: Emerging Therapies

Content Format:

Video

Credit Type:

--

Credits:

--
Metastatic Breast Cancer: Patient-Provider Communication Checklist

Content Format:

PDF

Credit Type:

--

Credits:

--
Key Decision Points in Neoadjuvant and Adjuvant Treatment Selection for Early-Stage HER2-Negative Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
My Thoughts on the Potential of AKT Inhibitors in Metastatic Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
The Evolving Treatment of Early Breast Cancer: Expert Answers to FAQs

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
The New Treatment Paradigm and Ongoing Questions for Early-Stage TNBC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Highlights From the 2022 San Antonio Breast Cancer Symposium

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

1.00
Expert Answers to FAQ on Neo/Adjuvant Therapy in Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Look Ahead to SABCS 2022

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
How Risk of Recurrence in HR-Positive/HER2-Negative Early Breast Cancer Impacts Therapeutic Choices

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2022 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
An Interactive Tool for Managing AEs With Oral Targeted Therapies for HR+, HER2– Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--